Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
暂无分享,去创建一个
A. Dingemans | G. Roemen | E. Speel | L. Hendriks | M. van Driel | M. Westenend | A. Brouns | R. Lunde | L. Moonen | D. Leunissen | Iris J. Robbesom-van den Berge | Annemariek H M Driessen | B. V. van Herpen | Z. Dekkers | Bas Heitzer
[1] Zengjie Zhang,et al. Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value , 2021, Frontiers in Oncology.
[2] T. Ochiya,et al. Extracellular vesicles in the development of organ‐specific metastasis , 2021, Journal of extracellular vesicles.
[3] N. Reinmuth,et al. A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial , 2020 .
[4] N. Reinmuth,et al. A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC - the ETOP and EORTC SPLENDOUR trial. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] R. Kimmig,et al. Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer , 2018, Clinical Cancer Research.
[6] A. Dingemans,et al. Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer. , 2018, Lung cancer.
[7] A. Del Fattore,et al. The Role of Extracellular Vesicles in Bone Metastasis , 2018, International journal of molecular sciences.
[8] C. C. H. J. Kuijpersa,et al. Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer , 2018 .
[9] M. Santarpia,et al. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway , 2017, Scientific Reports.
[10] S. Peters,et al. RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma , 2017, bioRxiv.
[11] M. Heymann,et al. RANK–RANKL signalling in cancer , 2016, Bioscience reports.
[12] Yibin Kang. Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis , 2016, Endocrinology and metabolism.
[13] K. O'Byrne,et al. Relationship Between EGFR Expression, EGFR Mutation Status, and the Efficacy of Chemotherapy Plus Cetuximab in FLEX Study Patients with Advanced Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] E. Smit,et al. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? , 2014, Lung cancer.
[15] W. Guo,et al. Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer , 2013, PloS one.
[16] M. Clemons,et al. Incidence and consequences of bone metastases in lung cancer patients , 2013, Journal of bone oncology.
[17] P. Clézardin,et al. RANK/RANKL pathway in cancer: Biological activity beyond bone? , 2012, Journal of bone oncology.
[18] T. Guise,et al. Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.
[19] Jie Gao,et al. Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas , 2010, BMC Cancer.
[20] R. Erben,et al. The EGFR network in bone biology and pathology , 2009, Trends in Endocrinology & Metabolism.
[21] F. Cappuzzo,et al. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer , 2009, Oncogene.
[22] Y. Okada,et al. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas , 2009, The Journal of pathology.
[23] H. Ryoo,et al. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross‐talking with RANK signaling , 2008, Journal of cellular physiology.
[24] S. M. Sims,et al. Regulation of cancer cell migration and bone metastasis by RANKL , 2006, Nature.
[25] M. Spitz,et al. Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] Elisa Rossi,et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. , 2005, Journal of the National Cancer Institute.
[27] Chan Zeng,et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] E. Margalioth,et al. Fatal attraction. , 1993, Fertility and sterility.